100% misunderstanding

There is a common misunderstanding that 100% visual inspection of biopharmaceutical products equates to 100% detection of defects. The 100% visual inspection the process is inherently probabilistic, meaning that identifying all defects is not guaranteed. The intent of this paper is to illustrate that the probabilistic nature of detection is well understood and aims, through examples, to dispel the misunderstandings associated with visual inspection. The authors hope this paper clarifies why 100% visual inspection ≠ 100% defect detection, and that the probabilistic nature is based in science and laid out as such in regulatory guidance.

This document is reserved for the use of BioPhorum members only.

I don't have access to this document

Make a selection below and submit your request. We will get back to you ASAP.

My company would like to become a member

If you're not sure if your company is a member of this Phorum, or if you would like to enquire on behalf of your company about becoming a member, please see our membership page.

Preview